(Q44233636)

1 December 2017

title

Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections (English)

1 reference

1 December 2017

1 reference

Milazzo I

1

1 reference

1 December 2017

Blandino G

2

1 reference

1 December 2017

Musumeci R

3

1 reference

1 December 2017

Nicoletti G

4

1 reference

1 December 2017

Lo Bue AM

5

1 reference

1 December 2017

Speciale A

6

1 reference

1 December 2017

publication date

1 December 2002

1 reference

International Journal of Antimicrobial Agents

1 December 2017

published in

1 reference

1 December 2017

volume

20

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

451-456

1 reference

Prevention of infective endocarditis: a review of the medical and dental literature

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

Prevotella and Porphyromonas infections in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

Chronic otitis media in children. Microbiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

Septic pulmonary embolism due to periodontal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

The pathogenesis of human periodontitis: an introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

The role of epidemiology in the study of periodontal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

Microbiology in the management of destructive periodontal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900190-5

7 January 2021

10.1016/S0924-8579(02)00190-5

Identifiers

DOI

1 reference

1 December 2017

1 reference